Fig. 1 | Scientific Reports

Fig. 1

From: MUC14 suppresses lung adenocarcinoma via integrin α8β6/PI3K/AKT/MAPK modulating cisplatin response and immunity

Fig. 1The alt text for this image may have been generated using AI.

Association of MUC14 with clinical outcomes in LUAD. (A,B) The Kaplan–Meier survival analysis for overall survival (OS) and free progressions (FPS) for different transmembrane mucins in lung cancer. (C) Expression of transmembrane mucins between cancer and normal in LUAD (GEPIA). (D) Venn diagram identifying MUC14 as the only transmembrane mucin associated with OS, FPT and cancer/normal expression. *P < 0.05; HR, Hazard ratio.

Back to article page